Membrane Proteome of Invasive Retinoblastoma: Differential Proteins and Biomarkers

Purpose: Retinoblastoma (RB) is a pediatric ocular cancer which is caused due to the aberrations in the RB1 gene. The changes in the membrane proteomics would help in understanding the development of the retinoblastoma and could identify candidates for biomarkers and therapy.

• Publication year

  2018

• Venue

  PROTEOMICS - Clinical Applications

• Publication date

  2018-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/prca.201700101PMID 29742327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic profiling of retinoblastoma by high resolution mass spectrometry

  2016cited by this paper
• Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach

  2016cited by this paper
• Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study

  2016cited by this paper
• Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers

  2016cited by this paper
• Retinoblastoma genetics in India: From research to implementation

  2015cited by this paper
• A population‐based study of retinoblastoma incidence and survival in Argentine children

  2014cited by this paper
• The genomic landscape of retinoblastoma: a review

  2014cited by this paper
• Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells.

  2013cited by this paper
• Retinoblastoma

  2012cited by this paper
• LC-MS/MS Analysis of Differentially Expressed Glioblastoma Membrane Proteome Reveals Altered Calcium Signaling and Other Protein Groups of Regulatory Functions*

  2012cited by this paper
• The incidence and distribution of retinoblastoma in Kenya

  2011cited by this paper
• The lamin protein family

  2011cited by this paper
• Will helicases contribute to the fight against malaria?

  2010cited by this paper
• Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors

  2010cited by this paper
• Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients.

  2010cited by this paper
• The nuclear envelope as a signaling node in development and disease.

  2009cited by this paper
• Membrane proteins and membrane proteomics

  2008cited by this paper
• Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research

  2007cited by this paper
• Differential expression of nuclear lamins in normal and cancerous prostate tissues.

  2006cited by this paper
• Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

  2006cited by this paper
• The application of mass spectrometry to membrane proteomics

  2003cited by this paper
• Proteome analysis of hepatocellular carcinoma.

  2002cited by this paper
• Identification of essential genes in cultured mammalian cells using small interfering RNAs.

  2001cited by this paper
• Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry

  2001cited by this paper
• Iron metabolism.

  1999cited by this paper
• The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.

  1997cited by this paper
• Second primary tumors in patients with hereditary retinoblastoma: A register‐based follow‐up study, 1945–1994

  1996cited by this paper
• The transmembrane segment of the human transferrin receptor functions as a signal peptide.

  1986cited by this paper

• B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma

  2026cites this paper
• From Dysplasia to Carcinoma: Expression Patterns of Dermokine, Matriptase, and Tryptase in OPMD.

  2025cites this paper
• Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities

  2024cites this paper
• Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma.

  2024cites this paper
• Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.

  2023cites this paper
• Protein profiling of WERI RB1 and etoposide resistant WERI ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma

  2022cites this paper
• Mass spectrometry-based retina proteomics.

  2022cites this paper
• Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma

  2022cites this paper
• Retinoblastoma: from discovery to clinical management

  2021cites this paper
• Peptide-based electrochemical biosensors utilized for protein detection.

  2021cites this paper
• Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing—Opening Pathways to New Therapeutic Strategies?

  2021cites this paper
• Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma

  2021cites this paper
• Biomarkers in retinoblastoma.

  2020cites this paper
• TRIM59 Promotes Retinoblastoma Progression by Activating the p38–MAPK Signaling Pathway

  2020cites this paper
• The development and clinical applications of proteomics: an Indian perspective

  2020cites this paper
• Clinical relevance of B7H3 expression in retinoblastoma

  2020cites this paper
• Screening and identification of key biomarkers for retinoblastoma

  2020influential citation
• Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis

  2020cites this paper
• Exploration of potential key pathways and genes in multiple ocular cancers through bioinformatics analysis

  2019cites this paper
• Middle-down approach: a choice to sequence and characterize proteins/proteomes by mass spectrometry

  2018cites this paper